OBJECTIVES: The aim of the study was to establish a scoring system to predict mortality in aortic valve procedures in adults [German Aortic Valve Score (German AV Score)] based upon the comprehensive data pool mandatory by law in Germany.
INTRODUCTION
In cardiac surgery, in-hospital mortality is accepted as one of the most important indicators for quality of care. However, the crude mortality of a given procedure fails to be a valid indicator of surgical quality because it depends on the risk profile of the specific patient population. Without taking into account different risk profiles, surgeons operating on patients with severe co-morbidities may appear to provide minor quality of treatment. In order to make surgical outcomes comparable, a valid risk adjustment model is mandatory. There is no doubt that political and public interest in institutional results has increased during recent years. Moreover, a reliable model to predict mortality may be extremely helpful with regard to both the informed consent of the patient and to give advice to the heart team. This becomes even more important when taking into account the emerging transcatheter techniques as an alternative to open heart surgery.
In Germany, control of therapeutic quality for isolated aortic valve procedures is obligatory according to the requirements of the German social code. We found that existing risk stratification models consistently overestimated the mortality observed in the ‡ Both authors contributed equally to this work. patient population in Germany. This was also true for the EuroSCORE with other populations [1] [2] [3] . Thus, the comprehensive national data pool in Germany was used to calculate predicted mortalities based on evaluated risk factors. The aim of this work is to present the German Aortic Valve Score (German AV Score; in Germany formerly named AKL-Score), a reliable new tool for risk adjustment of mortality in surgical and interventional treatment for aortic valve disease in adults.
MATERIALS AND METHODS

Study design
In Germany, documentation and quality benchmarking of cardiac care is mandatory for three well-defined procedures, namely isolated coronary bypass surgery, isolated aortic valve replacement including transcatheter aortic valve implantation (TAVI) and combined bypass and aortic valve replacement, each for patients aged ≥18 years. This allows for data acquisition across the complete German patient population who have undergone aortic valve replacement and TAVI. The mandatory data record includes pre-, intra-and postoperative parameters.
Comprehensive information on data acquisition requirements and definitions of obligatory parameters were provided to all participating institutions. The analysis was done using the 2008 data pool.
Data collection and entry
Data were collected in the hospitals and transferred to the national database at the BQS-Institute for quality benchmarking. Completeness of cases was tested systematically for each hospital by comparing referred documentation and analysis of data used for reimbursement. Incomplete individual data sets were identified by the lack of information in any of the mandatory fields and excluded from analysis. Validity of data was assured by means of multiple plausibility checks. The database was subjected to out-of-range error-checking operations and further algorithms to identify logical errors. At the time of data submission, hospitals were sent reports that informed site data managers on missing or inconsistent values. Hospitals were allowed to resubmit their data within the harvest period.
In 2008, records of 11 794 patients were sent to the national database by 81 institutions. Surgical aortic valve replacement was performed in 79 hospitals and TAVI in 25.
Data analysis
In a first step, various potential risk factors were tested with regard to their impact on in-hospital mortality and their statistical significance. The primary selection of risk factors was based on clinical knowledge and established risk models for heart diseases reported in the literature [4] [5] [6] [7] . For each of these parameters, prevalence and related mortality were calculated. The impact on mortality of each isolated parameter was studied using Fisher's exact test for 2 × 2 contingency tables. In order to examine common effects, a multiple regression model was developed. The use of a multiple regression model allows not only for conclusions to be drawn about the impact of individual risk factors on a binary outcome variable, but also for the simultaneous impact of various risk factors to be quantified. The final selection of parameters was done by backward and forward selection. At the beginning, all potential parameters were included.
Variables showing the highest P-value were eliminated consecutively down to a 0.05 level calculated by the Wald chi-squared test. Thereafter, each rejected factor was included again to test its common influence with the others.
Calibration was tested using the Hosmer-Lemeshow method [8] . Patients were grouped into 10 risk classes based on expected mortalities calculated from the result of the logistic regression model. Thus, the observed mortalities in these groups coincided with the predicted ones proven by chi-squared test. The potential for discrimination of in-hospital mortality was ascertained by calculating the area under the receiver operating characteristic (ROC) curve.
All calculations were done using the statistical computer package SPSS, versions 16.0.2 and 19.0.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
In 11 147 of 11 794 cases, the transmitted mandatory data sets were evaluable. Thus, the overall rate of completeness reached 94.5%. The completeness of data sets for isolated surgical aortic valve replacement was 94.7% (10 574 of 11 160). The median for all participating hospitals was 99.3%, ranging from 23.8 to 100%. Only six institutions delivered incomplete data for more than 10% of their patients. In cases of TAVI, the overall completeness was lower than in the surgical group, at 90.4% (573 of 634), ranging from 37.5 to 100%. Data are shown in Figure 1 .
Patient characteristics
Of the patients, 44.8% were female and 55.2% male. The study population was divided into six age groups, starting with 18-65 years, four 5 year intervals up to 85 years and one highest age group of >85 years. Of the patients, 13.6% were aged between 81 and 85 years, and 4.7% were aged 86 years or older. Detailed information is given in Severe congestive heart failure, classified as New York Heart Association (NYHA) class IV, was found in 8.4% of patients, critical preoperative status (as defined in Table 1 ) in 6.7% of the patients, and 3.9% of the procedures were classified as emergency cases. Of the patients, 11.1% have had previous heart or thoracic aortic surgery, and 4.4% suffered from acute bacterial or fungal endocarditis.
Left ventricular ejection fraction (LVEF) of at least 50% was defined as normal (68.1% of the patients), as moderately reduced with a range of 30-50% (24.8%) and as poor if lower than 30% (7.1%). Pulmonary hypertension with a systolic pulmonary arterial pressure exceeding 60 mmHg was diagnosed in 13.1% of the patients. Chronic obstructive pulmonary disease (COPD) affected 12.6% of the patients in this study. Sixteen per cent of the cases showed extracardiac arteriopathy. Table 1 presents detailed information on prevalence, in-hospital mortality, P-values and odds ratios of all the parameters included in the first-step univariate analysis. The parameter 'left main disease' showed the lowest prevalence (0.9%, n = 102). This variable was not found to be significant in the final multiple logistic regression model. The parameter 'myocardial infarction within previous 21 days' exhibited the lowest prevalence (1.2%, n = 134) amongst all risk factors included in the model. All other variables incorporated in the final multiple regression model showed a prevalence of at least 3%, respectively more than 400 patients.
Statistical analysis
Mortality in the overall patient group was 3.7% (416 of 11 147). There were 355 deaths [3.4%, 95% confidence interval (CI) 3.0-3.7%; n = 10 574] in the conventional aortic valve replacement group and 61 deaths (10.6%, 95% CI 8.2-13.5%, n = 573) in the TAVI group.
Using the described multiple logistic regression, 15 risk factors were proven to exhibit common influence on mortality after isolated aortic valve procedures with statistical significance of P < 0.05. These factors were age, sex, weight, heart failure NYHA class IV, myocardial infarction within previous 21 days, critical preoperative status, pulmonary arterial hypertension, atrial fibrillation or other arrhythmia, left ventricular dysfunction, previous heart or thoracic aortic surgery, acute endocarditis, extracardiac arterial disease, COPD, renal failure and emergency surgery. Table 2 summarizes the risk factors of the German AV Score, supplemented by detailed information on regression coefficients, odds ratios and P-values. No additional impact has been found for congestive heart failure NYHA class III (P = 0.144), pulmonary disease other than COPD (P = 0.885), diabetes (P = 0.211), neurological dysfunction (P = 0.342), previous percutaneous coronary intervention (P = 0.909), angina pectoris Canadian Cardiovascular Society class IV (P = 0.655), left main disease (P = 0.533) and angina as primary symptom (P = 0.455). By using the definition of the risk factors as shown in Table 1 , higher numeric values of the regression coefficients correlate with a higher impact on mortality.
The odds ratio for each risk factor in Table 2 represents the factor by which the odds of dying increases given the same values with all other risks. In emergency procedures, the odds of dying during the hospital stay were 2.88 times higher in comparison to non-emergency cases, provided all other risks were equal in those groups. Preoperative renal failure or dialysis was associated with an odds ratio of 3.2 given equal values for all the other risk factors.
Age, BMI and left ventricular function were categorized in more than two groups. The interpretation of odds ratios for these factors has to be done in relation to the corresponding reference categories; therefore, patients in the age group 76-80 years have 3.6 times higher odds of dying during the hospital stay than patients aged between 18 and 65 years. The risk correlates with age. The reference category for LVEF was defined as 'good or ≥50%' and for BMI as 'between 22 and 35 kg/m 2 '. The precise risk, p, can be calculated by taking the sum X of the regression coefficients (Table 2) according to the present risk factors of a specific patient using the following formula:
To obtain a quick feeling for the true risk, Table 3 facilitates an easy paper-based calculation by simply summating the regression coefficients belonging to the risk factors of a specific medical situation. The summation has to be done without the value of the intercept. The calculated sum can then be assigned to the expected mortality by means of Table 3 . For patients without any risk factors, the expected mortality is calculated to be 0.4%. For example, in a case of a female patient, aged 78 years, with extracardiac arterial disease and moderately depressed LVEF between 30 and 50% and no further risk factors of the German AV Score, the regression coefficient of the risk factors sums up to 2.291 (= 0.357 + 1.292 + 0.359 + 0.283). Table 3 displays the expected in-hospital mortality as being within 3.7-4.7%.
The calibration of the model was tested by the HosmerLemeshow method. Table 4 presents the predicted and observed mortalities assigned to 10 risk groups. The derived P-value of 0.776 confirms a valid accordance of predicted and observed mortality. The area under the ROC curve with a value of 0.808 further affirmed the quality of discrimination of the established model (Fig. 2) . 
DISCUSSION
Risk scoring systems are used for several purposes. Among them, one of the most important is the fair comparison of outcomes between medical institutions to support their continuous effort in improving surgical and interventional results. Moreover, at the present time there is increasing interest in the assessment of quality of care and interhospital comparison by the public, government departments and health insurance companies providing reimbursement. From a medical point of view, decision making for an individual patient requires information on both the natural history of the cardiac disease to be surgically treated and the assumed risk of the procedure. To do this, several riskpredicting models have been developed and used. However, there is no doubt that there is an ongoing need for regular updating of predictive algorithms and their validation at local levels [9] . In addition, re-evaluation of risk predicting models is especially important in order to keep up with the emergence of new therapies and to avoid misinterpretation of former and ongoing clinical trials. From an ethical point of view, this knowledge is also important for obtaining informed consent from the patient. It is generally agreed that the widely used EuroSCORE overestimates mortality in most patient collectives [10] [11] [12] . Additionally, in our opinion high predicted mortalities in older patient groups have been greatly misused in pushing forward the introduction and the establishment of TAVI procedures. To solve this problem, the EuroSCORE II was developed [13] . Some authors have found EuroSCORE II to be a useful development of the previous version, with improved predictive performance [14] . However, data acquisition in various countries, in a large number of participating centres, some of them with small patient numbers, and questionable completeness of data have raised some substantial questions concerning its overall validity. Beyond that, some statistical questions have been raised recently [15] . Moreover, the presumption that a scoring system may be exhaustively comprehensive for all patient groups, cardiac diseases and therapies is certainly misleading [16, 17] . EuroSCORE II was also based on a data set consisting mainly of coronary procedures. It may therefore be less well adapted to aortic procedures than a specific score as presented in the present study. This has been mentioned by other authors too [18] [19] [20] [21] . Given the importance of these issues, we decided to use the specific and well-defined data pool of the mandatory national benchmarking project to develop scores tailored for isolated coronary bypass surgery, isolated aortic valve procedures and combined aortic and coronary procedures. In this work, the German AV Score referring to isolated aortic valve procedures is presented. The primary goal of this work was to establish a valid tool for risk adjustment and interhospital benchmarking well adherent to the daily practice in Germany.
The score was calculated on basis of the year 2008 data. The new score was used for mandatory interhospital benchmarking in 2008 and the following years. In the overall German patient population, the observed-to-expected mortality ratio was stable, showing only minimal deviation in 2009. A weakness of the study might be the low number of TAVI procedures included during this early period of transcatheter techniques. However, in publishing the score for the first time, we felt obligated to present the primary data. Re-evaluation of the score is envisaged.
In heart surgery, it has long been established that hospital mortality is an important indicator of quality of care [16, 19, 22] . However, it has been noted that haemodynamic results, longterm survival and quality of daily life are as important as primary mortality [23] . This is certainly true. However, those data are not included in the mandatory data set. With regard to the validity of data and compliance of surgical and cardiological centres, we avoided to add parameters to the mandatory battery. For these reasons, we have chosen in-hospital mortality as the primary outcome variable, defined as the status of the patient at discharge after the operation. In contrast to 30 day or even 60 or 90 day mortality, in-hospital mortality is a well-fixed and clear-cut binary outcome parameter, which can easily be crosschecked with the data pool provided by the hospital administration system. In this way, bias from phone calls or postal requests is avoided.
Several features of data collection and processing were included to enhance the accuracy of the data pool. Multiple computerized checks were done to test the internal consistency of data for a given patient. On-site visits were made to randomly selected centres. We believe this to be an important and crucial validation mechanism. In summary, the data basis of this work is comprehensive and population based; it is sufficiently audited for accuracy and completeness. Risk parameters were chosen with respect to availability, objectivity and validity.
The Hosmer-Lemeshow method [8] exhibited sufficient concordance in the predicted and observed mortalities. Moreover, the area under the ROC curve [24] was calculated to exceed 0.8, thereby demonstrating a high quality of discrimination for this model.
In order not to diminish the number of TAVI cases for calculation further, we did not divide data into a learning and validation part. As a result of this, there may remain some questions regarding validity in further patient groups.
Given that the score was designed for interhospital comparisons, we did not divide patients into an open surgical and a transcatheter group. It is obvious that there might be some influence of a procedure per se on the outcome. From an interpretational point of view, this can be considered as a limitation of the presented work. As the portion of TAVI procedures (5.1%) was low to that date, TAVI or surgical aortic valve replacement was not tested yet as an independent risk factor. In contrast, we have chosen a patient-related point of view. The model is diagnosis based and defines the indication for a special procedure as a treatment decision that should not be statistically excluded. For that reason, we included open surgical and transcatheter techniques in one model. Nevertheless, in contrast to other risk scores, we concentrated on a well-defined pathology, aortic valve disease in the adult. Thus, we expected to increase the accuracy of estimation of the expected mortality.
The overall in-hospital mortality for open valve surgery was 3.4% in our patient group. This fits very well with the figures reported by others [18, 19] . Given that cardiac surgeons were early adopters of data collection and analysis in Germany, the external mandatory quality control was immediately accepted. It is important to note that over the years there has always been a very high accordance of results reported to the voluntary registry of the German Society for Thoracic and Cardiovascular Surgery (DGTHG) and the mandatory data set. In Germany in 2008, the in-hospital mortality following isolated aortic valve surgery in the adult was 3.3% as published by the DGTHG [25] .
It is well known that predictive models work best in the development series at a special location. For this reason, the German AV Score fits best to the population in Germany. The calculation was done retrospectively. It has been primarily developed for quality comparisons and interhospital benchmarking, and can be re-evaluated and recalibrated on basis of the latest data annually sent to the mandatory national benchmarking project. We believe this score to be a reliable tool when discussing and developing treatment guidelines. The presented score allows for comparison of predicted and observed mortality resulting from open aortic valve surgery and transcatheter techniques in low-, moderate-and high-risk groups. In our opinion, the German AV Score can be applied to further populations, thus testing its predictive accuracy. We therefore encourage other cardiac specialists to apply this score to their patients.
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